MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 206 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,076,000 | -92.3% | 30,517 | -90.8% | 0.02% | -91.5% |
| Q4 2021 | $13,888,000 | -27.9% | 331,463 | -15.5% | 0.20% | -36.6% |
| Q3 2021 | $19,257,000 | +1.9% | 392,361 | -13.4% | 0.31% | -10.8% |
| Q2 2021 | $18,901,000 | +3.2% | 452,944 | -11.9% | 0.35% | -13.3% |
| Q1 2021 | $18,317,000 | +5.5% | 513,957 | -17.0% | 0.41% | -11.9% |
| Q4 2020 | $17,369,000 | – | 619,217 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $615,958,000 | 21.97% |
| Nekton Capital Ltd. | 896,469 | $25,469,000 | 8.21% |
| Pavadi Capital LLC | 158,520 | $4,504,000 | 4.08% |
| Curi Wealth Management, LLC | 430,451 | $12,229,000 | 2.35% |
| Ownership Capital B.V. | 4,392,050 | $124,778,000 | 2.14% |
| Select Equity Group, L.P. | 19,114,926 | $543,055,000 | 1.74% |
| MOODY ALDRICH PARTNERS LLC | 285,091 | $8,099,000 | 1.59% |
| Beck Bode, LLC | 178,916 | $5,083,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 24,500 | $696,000 | 0.97% |
| Eversept Partners, LP | 425,364 | $12,084,591 | 0.86% |